Xuejing Shao

All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages

Qian Zhou, Miao Xian, Senfeng Xiang et al. · Cancer Immunology Research · 2017 · 151 citations

Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy

Liguo Wang, Xuejing Shao, Tianbai Zhong et al. · Nature Chemical Biology · 2021 · 150 citations

Aml Differentiation Therapy, Receptor Tyrosine Kinase, Cell Biology +4

Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2

Meidan Ying, Xuejing Shao, Hui Jing et al. · Blood · 2018 · 100 citations · Full text

Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells

Xuejing Shao, Senfeng Xiang, Yingqian Chen et al. · Acta Pharmacologica Sinica · 2019 · 93 citations · Full text

Medicine, Stem Cells, Osteosarcoma Cells +9

The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival

Jiajia Shen, Pengyu Li, Xuejing Shao et al. · Cancer Research · 2017 · 62 citations · Full text